{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360565166133146752.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.thromres.2017.12.014"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0049384817306151?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0049384817306151?httpAccept=text/plain"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca2+ mobilization and ERK phosphorylation in healthy Japanese subjects"}],"description":[{"notation":[{"@value":"Abstract   Background  Thrombin belongs to the most potent platelet agonists and activates human platelets through GPIbα and two protease activated receptors (PARs), PAR1 and PAR4. However, the details of thrombin receptor system, especially the role of PAR4 on human platelet activation is still not clear.    Objectives  We found a significant difference in PAR4-activating peptide (PAR4-AP)-induced, but not PAR1-AP, platelet aggregation between healthy Japanese subjects. Sequencing analysis revealed a single nucleotide change in PAR4 gene F2RL3 (SNP rs773902) leading to Ala120Thr variant. To elucidate the role of PAR4 in human platelet activation, we examined if platelet activation induced by PAR4-AP may be associated with PAR4 genotype.    Methods  Platelets from 202 healthy Japanese volunteers were genetically analyzed and determined the genotype frequency of rs773902. Agonist induced platelet aggregation, integrin αIIbβ3 activation, granule release, Ca2+ mobilization, and activation of ERK and MLC were evaluated. The specificity of effects observed in platelets was confirmed in 293T cells transfected PAR4-Thr120 or Ala120.    Results  The frequencies of PAR4 variant Thr/Thr120, Ala/Thr120, and Ala/Ala 120 were 5.9, 37.1, and 57.0%, respectively. Platelets with Thr/Thr120 showed significantly higher reactivity in PAR4-AP-induced platelet aggregation, αIIbβ3 activation and granule release compared to platelets with Ala/Ala120. PAR4-AP induced higher Ca2+ mobilization and ERK activation in platelets with Thr/Thr120 than Ala/Ala120. Ca2+ mobilization and ERK activation were also increased in 293T cells transfected with PAR4-Thr120 compared to Ala120.    Conclusion  Our data suggested that PAR4-AP-induced platelet reactivity between PAR4 rs773902 was associated with altered intensity of Ca2+ mobilization and ERK activation."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380566394312824961","@type":"Researcher","foaf:name":[{"@value":"Yoichiro Morikawa"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751148767616","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"20705214"},{"@type":"NRID","@value":"1000020705214"},{"@type":"NRID","@value":"9000242081173"},{"@type":"NRID","@value":"9000415348856"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/hikato"}],"foaf:name":[{"@value":"Hisashi Kato"}]},{"@id":"https://cir.nii.ac.jp/crid/1420282801182908672","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"10432535"},{"@type":"NRID","@value":"1000010432535"},{"@type":"NRID","@value":"9000020965682"},{"@type":"NRID","@value":"9000403298681"},{"@type":"NRID","@value":"9000404106606"},{"@type":"NRID","@value":"9000411018027"},{"@type":"NRID","@value":"9000018774562"},{"@type":"NRID","@value":"9000018772636"},{"@type":"NRID","@value":"9000001032037"},{"@type":"NRID","@value":"9000262365449"},{"@type":"NRID","@value":"9000412589219"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/hirok86"}],"foaf:name":[{"@value":"Hirokazu Kashiwagi"}]},{"@id":"https://cir.nii.ac.jp/crid/1380566394312824962","@type":"Researcher","foaf:name":[{"@value":"Nobuko Nishiura"}]},{"@id":"https://cir.nii.ac.jp/crid/1380566394312824964","@type":"Researcher","foaf:name":[{"@value":"Keigo Akuta"}]},{"@id":"https://cir.nii.ac.jp/crid/1030003658420038784","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"00303959"},{"@type":"NRID","@value":"1000000303959"},{"@type":"NRID","@value":"9000000430066"}],"foaf:name":[{"@value":"Shigenori Honda"}]},{"@id":"https://cir.nii.ac.jp/crid/1380566394312824963","@type":"Researcher","foaf:name":[{"@value":"Yuzuru Kanakura"}]},{"@id":"https://cir.nii.ac.jp/crid/1420001326213585152","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"80252667"},{"@type":"NRID","@value":"1000080252667"},{"@type":"NRID","@value":"9000000605695"},{"@type":"NRID","@value":"9000258727829"},{"@type":"NRID","@value":"9000391659447"},{"@type":"NRID","@value":"9000018774773"},{"@type":"NRID","@value":"9000240064238"},{"@type":"NRID","@value":"9000404106613"},{"@type":"NRID","@value":"9000403545903"},{"@type":"NRID","@value":"9000001388229"},{"@type":"NRID","@value":"9000254441295"},{"@type":"NRID","@value":"9000021342215"},{"@type":"NRID","@value":"9000242081174"},{"@type":"NRID","@value":"9000258045456"},{"@type":"NRID","@value":"9000001434851"},{"@type":"NRID","@value":"9000007075479"},{"@type":"NRID","@value":"9000283533709"},{"@type":"NRID","@value":"9000262365452"},{"@type":"NRID","@value":"9000262365450"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0042761"}],"foaf:name":[{"@value":"Yoshiaki Tomiyama"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00493848"}],"prism:publicationName":[{"@value":"Thrombosis Research"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2018-02","prism:volume":"162","prism:startingPage":"44","prism:endingPage":"52"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0049384817306151?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0049384817306151?httpAccept=text/plain"}],"createdAt":"2017-12-24","modifiedAt":"2022-06-19","project":[{"@id":"https://cir.nii.ac.jp/crid/1040000781851065472","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"15K09454"},{"@type":"JGN","@value":"JP15K09454"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K09454/"}],"notation":[{"@language":"ja","@value":"新規実験系を用いたインテグリン機能制御分子の解析、同定とその応用"},{"@language":"en","@value":"Identification and characterization of integrin inside-out signaling molecules employing a newly developed expeimental system"}]},{"@id":"https://cir.nii.ac.jp/crid/1040000781915560832","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"16K09826"},{"@type":"JGN","@value":"JP16K09826"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-16K09826/"}],"notation":[{"@language":"ja","@value":"血小板インテグリンシグナル機構の解明と血管病変形成に関する検討"},{"@language":"en","@value":"Analysis of platelet integrin signaling and association with vascular diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282256827792768","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"15K09463"},{"@type":"JGN","@value":"JP15K09463"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-15K09463/"}],"notation":[{"@language":"ja","@value":"β3インテグリン機能発現におけるキンドリンの役割解明と新たな因子の探索・同定"},{"@language":"en","@value":"Elucidation of the role of kindlin in the functional expression of beta3 integrins and investigation of the kindlin-related new molecules"}]},{"@id":"https://cir.nii.ac.jp/crid/1040282256977346688","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"18K08327"},{"@type":"JGN","@value":"JP18K08327"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18K08327/"}],"notation":[{"@language":"ja","@value":"血小板インテグリン活性化ダイナミクスを制御する分子機構の網羅的解析"},{"@language":"en","@value":"Analysis of regulatory mechanism for platelet integrin activation kinetics"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360011143907469184","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145683441920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Impaired platelet function in a patient with P2Y12 deficiency caused by a mutation in the translation initiation codon"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011145920521728","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146299500160","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711737129984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Human CalDAG-GEFI deficiency increases bleeding and delays αIIbβ3 activation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619641954432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Primacy of β1 Integrin Activation in the Metastatic Cascade"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292620811734016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mechanism of Race-Dependent Platelet Activation Through the Protease-Activated Receptor-4 and Gq Signaling Axis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093797531136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"SHPS‐1 negatively regulates integrin αIIbβ3 function through CD47 without disturbing FAK phosphorylation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093858049664","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Determinants of Thrombin Receptor Cleavage. RECEPTOR DOMAINS INVOLVED, SPECIFICITY, AND ROLE OF THE P3 ASPARTATE"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574093940704896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Protease‐activated receptor 4: from structure to function and back again"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574095123461504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A dual thrombin receptor system for platelet activation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855568439614848","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855569194863744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Domains specifying thrombin–receptor interaction"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570640684800","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation."}]},{"@id":"https://cir.nii.ac.jp/crid/1360855571206484992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"P2Y12 receptor‐mediated potentiation of thrombin‐induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044154442496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Role of the thrombin receptor in development and evidence for a second receptor"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044624281088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Common variants in the human platelet PAR4 thrombin receptor alter platelet function and differ by race"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045922322944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"G13 is an essential mediator of platelet activation in hemostasis and thrombosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046131641088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Systems biology insights into the meaning of the platelet's dual‐receptor thrombin signaling"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520056417792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"PAR3 is a cofactor for PAR4 activation by thrombin"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520097383040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Biphasic Kinetics of Activation and Signaling for PAR1 and PAR4 Thrombin Receptors in Platelets"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418520459378560","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Stroke Incidence and Mortality Correlated to Stroke Risk Factors in the WHO MONICA Project"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994422477696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"REVIEW ARTICLES: Platelet G protein-coupled receptors in hemostasis and thrombosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995991754880","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Defective platelet activation in Gαq-deficient mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468720080384","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Physical Association of the P2Y12 Receptor with PAR4 Regulates Arrestin-Mediated Akt Activation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468813696640","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Structure-Function Analysis of Protease-activated Receptor 4 Tethered Ligand Peptides"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469145624064","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Differential Signaling by Protease-Activated Receptors: Implications for Therapeutic Targeting"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469824484992","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470820664448","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Protease‐activated receptors in hemostasis, thrombosis and vascular biology"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470824966016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943697480832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Protease-activated Receptor 1 (PAR1) and PAR4 Heterodimers Are Required for PAR1-enhanced Cleavage of PAR4 by α-Thrombin"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419010230656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents."}]},{"@id":"https://cir.nii.ac.jp/crid/1362544419777239296","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca2+ Mobilization and Synergistic P2Y12 Receptor Activation"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420840220928","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Platelets in atherothrombosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825893296150656","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Extracellular Mediators in Atherosclerosis and Thrombosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894419621760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Targeting PAR1: Now What?"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894704395136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Platelet Shape Change Is Mediated by both Calcium-dependent and -independent Signaling Pathways"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894850765696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Platelet receptors as therapeutic targets: Past, present and future"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894931206016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825896210835840","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Protease-activated receptor-4 and purinergic receptor P2Y12 dimerize, co-internalize, and activate Akt signaling via endosomal recruitment of β-arrestin"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369106490368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Inhibition of protease‐activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369622522496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mechanisms of Thrombin Receptor Agonist Specificity"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845906173568","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Vorapaxar in the Secondary Prevention of Atherothrombotic Events"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319658386304","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides."}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319881011072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mechanisms of platelet activation by thrombin: A short history"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319981411072","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Signaling During Platelet Adhesion and Activation"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951793622261248","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Protease-Activated Receptors: Contribution to Physiology and Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795191771136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795723122048","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Mitogen‐activated protein kinases in hemostasis and thrombosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951796112119040","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Differential Activation of Cytosolic Phospholipase A2 (cPLA2) by Thrombin and Thrombin Receptor Agonist Peptide in Human Platelets. EVIDENCE FOR ACTIVATION OF cPLA2 INDEPENDENT OF THE MITOGEN-ACTIVATED PROTEIN KINASES ERK1/2"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268527265536","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cloning and characterization of human protease-activated receptor 4"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233268754335616","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Activation of Platelet Function Through G Protein–Coupled Receptors"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269388497792","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Role of thrombin signalling in platelets in haemostasis and thrombosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269882351872","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270297167744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233270328689920","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Binding of human α-thrombin to platelet GpIb: energetics and functional effects"}]},{"@id":"https://cir.nii.ac.jp/crid/1372539180323177991","@type":"Product","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679408602496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Explanation for the Japanese Paradox: Prevention of Increase in Coronary Heart Disease and Reduction in Stroke"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.thromres.2017.12.014"},{"@type":"KAKEN","@value":"PRODUCT-21859290"},{"@type":"KAKEN","@value":"PRODUCT-21859354"},{"@type":"KAKEN","@value":"PRODUCT-22112955"},{"@type":"KAKEN","@value":"PRODUCT-22456003"},{"@type":"OPENAIRE","@value":"doi_dedup___::17ddb46707c84d03ccedde5930aa747b"}]}